Semnur Pharmaceuticals, Inc.

SMNR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 10, 2026 10-Q
424B3 Jul 7, 2026 424B3
8-K Jul 7, 2026 8-K
424B3 Jul 1, 2026 424B3
SCHEDULE 13D/A Jun 26, 2026
4 Jun 26, 2026 4
8-K Jun 25, 2026 8-K
424B3 Jun 15, 2026 424B3
424B3 Jun 15, 2026 424B3
EFFECT May 18, 2026
10-Q May 13, 2026 10-Q
POS AM May 12, 2026 POS AM
ARS Apr 30, 2026 ARS
DEF 14A Apr 30, 2026 DEF 14A
8-K Apr 23, 2026 8-K
8-K Mar 17, 2026 8-K
10-K Feb 27, 2026 10-K
EFFECT Dec 29, 2025
424B3 Dec 29, 2025 424B3
CORRESP Dec 23, 2025
S-1/A Dec 19, 2025 S-1/A
S-8 Dec 3, 2025 S-8
S-8 Dec 3, 2025 S-8
8-K Dec 3, 2025 8-K
10-Q Nov 12, 2025 10-Q
← Newer Page 1 of 9 · 220 filings Older →